Stay updated on Switching to Cabotegravir and Rilpivirine: Clinical Trial

Sign up to get notified when there's something new on the Switching to Cabotegravir and Rilpivirine: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Switching to Cabotegravir and Rilpivirine: Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Several existing study locations across the United States, Germany, Italy, South Africa, and Spain now have more specific postal codes or regional labels. The listed cities remain the same, with the update clarifying their location details.
    Difference
    1%
    Check dated 2026-11-15T14:13:40.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now displays the clinical trial record, including study details, results measures, eligibility criteria, locations, and supporting documents, rather than a 403 error page.
    Difference
    100%
    Check dated 2026-11-08T13:55:22.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:13:34.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A site-wide banner announces that NIH is transitioning to the term “Super Intelligence” in place of “Artificial Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T14:07:49.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-18T14:34:43.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer's site revision identifier updates from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T15:17:22.000Z thumbnail image

Stay in the know with updates to Switching to Cabotegravir and Rilpivirine: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Switching to Cabotegravir and Rilpivirine: Clinical Trial page.